Literature DB >> 23666450

Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis.

Kenneth Mayer1, Brian Gazzard, José M Zuniga, K Rivet Amico, Jane Anderson, Yusef Azad, Gus Cairns, Nikos Dedes, Chris Duncombe, Sarah J Fidler, Reuben Granich, Michael A Horberg, Sheena McCormack, Julio S G Montaner, Helen Rees, Bruce Schackman, Papa Salif Sow.   

Abstract

In the context of emerging evidence related to preexposure prophylaxis and HIV treatment as prevention, an evidence summit was held in mid-2012 to discuss the current state of the science and to provide a platform for consensus building around whether and how these prevention strategies might be implemented globally. Health care providers, researchers, policy makers, people living with HIV/AIDS, and representatives of government authorities, donor agencies, pharmaceutical companies, advocacy organizations, and professional associations attended from 52 countries. An international advisory committee was convened to identify key messages and recommendations based upon the data presented and discussed at the summit. The advisory committee further worked to develop this consensus statement meant to assist relevant stakeholders in taking stock and mapping out a route forward to enhance the HIV prevention armamentarium.

Entities:  

Keywords:  HIV; biobehavioral; preexposure prophylaxis; prevention; treatment as prevention

Mesh:

Substances:

Year:  2013        PMID: 23666450     DOI: 10.1177/2325957413475839

Source DB:  PubMed          Journal:  J Int Assoc Provid AIDS Care        ISSN: 2325-9574


  19 in total

1.  Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community.

Authors:  Sandra A Springer; Frederick L Altice; Maua Herme; Angela Di Paola
Journal:  Contemp Clin Trials       Date:  2013-12-31       Impact factor: 2.226

2.  Determining the Cost-Savings Threshold for HIV Adherence Intervention Studies for Persons with Serious Mental Illness and HIV.

Authors:  Evan S Wu; Aileen Rothbard; David R Holtgrave; Michael B Blank
Journal:  Community Ment Health J       Date:  2014-12-23

3.  Ethics and pre-exposure prophylaxis for HIV infection.

Authors:  Jeremy Sugarman; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

4.  The impact of anticipated HIV stigma on delays in HIV testing behaviors: findings from a community-based sample of men who have sex with men and transgender women in New York City.

Authors:  Sarit A Golub; Kristi E Gamarel
Journal:  AIDS Patient Care STDS       Date:  2013-10-18       Impact factor: 5.078

5.  An omitted level: an examination of relational orientations and viral suppression among HIV serodiscordant male couples.

Authors:  Kristi E Gamarel; Torsten B Neilands; Sarit A Golub; Mallory O Johnson
Journal:  J Acquir Immune Defic Syndr       Date:  2014-06-01       Impact factor: 3.731

Review 6.  Stakeholder Engagement in HIV Cure Research: Lessons Learned from Other HIV Interventions and the Way Forward.

Authors:  Ying-Ru Lo; Carissa Chu; Jintanat Ananworanich; Jean-Louis Excler; Joseph D Tucker
Journal:  AIDS Patient Care STDS       Date:  2015-05-18       Impact factor: 5.078

Review 7.  HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials.

Authors:  Nittaya Phanuphak; Ying-Ru Lo; Yiming Shao; Sunil Suhas Solomon; Robert J O'Connell; Sodsai Tovanabutra; David Chang; Jerome H Kim; Jean Louis Excler
Journal:  AIDS Res Hum Retroviruses       Date:  2015-06-24       Impact factor: 2.205

8.  Facilitators and barriers affecting PrEP adherence among Thai men who have sex with men (MSM) in the HPTN 067/ADAPT Study.

Authors:  Tareerat Chemnasiri; Anchalee Varangrat; K Rivet Amico; Anupong Chitwarakorn; Bonnie J Dye; Robert M Grant; Timothy H Holtz
Journal:  AIDS Care       Date:  2019-06-03

9.  Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence.

Authors:  K Rivet Amico; Michael J Stirratt
Journal:  Clin Infect Dis       Date:  2014-07       Impact factor: 9.079

10.  Attitude towards antiretroviral Pre-Exposure Prophylaxis (PrEP) prescription among HIV specialists.

Authors:  Vincenzo Puro; Antonio Palummieri; Gabriella De Carli; Pierluca Piselli; Giuseppe Ippolito
Journal:  BMC Infect Dis       Date:  2013-05-14       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.